International across sector initiative to bring #dementia diagnostics closer to the public through a customisable cognitive and #biomarker screening platform.
📢 @predictom Level 2 Clinical Study has started. At Level 2, participants will receive check-up by neurologist (specialists), different cognitive tests, blood tests, MRI scan, PET scan (at certain clinical sites), Lumbar pucture etc. https://t.co/sAFswiMQlV
@predictom is sharing the clinical study progress openly—because we believe that each participant deserves to see how his/her involvement drives real scientific advances. https://t.co/s223YLdQ0T
More scientific evidences show blood biomarker as accurate tools for detecting #Alzheimer's diseases.
In @predictom , we include the finger-prick blood tests in clinical study. How could this hassle-free test help to detect #Alzheimers diseases? https://t.co/acYB2E5NZr
In addition to Banking App, @predictom Level 1 clinical study includes an innovative digital test 'BrainCheck Assess' to make brain health checks simple and accessible.
Thanks to BrainCheck, a US partner in @predictom.
https://t.co/d9nkEwYBxT
Congratulations to Pharmacoidea Ltd. for being the winner of Most Valuable Breakthrough/Discovery Award by Global Pharma Awards 2025. Read more about the Breakthrough https://t.co/wSUISiuAnM
'Oh no! I forgot my pin.' 'Oh no! I keyed in the wrong number.' Can these functional changes be studied and implied? In @predictom Level 1 clinical study, we have included advanced digital cognitive test - Banking App. Read how this is being designed.
https://t.co/9D9pINwSxN
Lucas Paletta and team from JOANNEUM RESEARCH are bringing you the eye-tracking test in PREDICTOM - IHI project clinical study. Do you want to know how eyes are revealing our brain works?https://t.co/UdzjYIQM57
In celebration for World #Alzheimer's Day (21st Sep), @predictom is presenting you a novel blood-based biomarker - Syndecan-3 (SDC3).
https://t.co/wSUISiuAnM
🤔 Over 50? Join the PREDICTOM Study and Help Advance Brain Health!
Would you like to help us understand how to reduce the risk of developing Alzheimer’s Disease? We are now recruiting voluntaries to join our study.
https://t.co/TaGnGf2z1t
@predictom launchesstandardized MRI protocol at Organization for Human Brain Mapping 2025 annual meeting and AAIC2025.
MR protocol harmonization is crucial to limit biases in AD biomarker prediction, says Brice Fernandez and Ana Beatriz Solana. https://t.co/d3pfTZ9mTK
EEG brain scans can detect early signs of Alzheimer’s—even before symptoms appear. "Even mild memory concerns can reflect real brain changes", says Dr. Lazarou, CERTH. https://t.co/MYHzrI8fG6
The @predictom project recently launched a risk reduction leaflet in four languages! It was developed by @icometrix and @AlzheimerEurope and in collaboration with @UNIGEnews
https://t.co/1serQ0edOW
Did you know that you can reduce your risk of developing #dementia?
WP6 & peers have produced leaflets to all citizens based on The Lancet 2024 report. Our free leaflets are available in English, German, Spanish and French.
https://t.co/9LzWr4d2aA
GE HealthCare is responsible for developing & implementing the platform, and integrating data, algorithms and automatically extracted features by leveraging the company’s strong expertise in MR imaging, leading the discovery of MR imaging-based biomarkers. https://t.co/kjT0cvALy3
🙌Can EEG-derived connectivity metrics help us to early detect and monitor #Alzheimer's Diseases progression?
Read our journal article "Exploring Functional Brain Networks in Alzheimer’s Disease Using Resting State EEG Signals" https://t.co/WOTTf69Vzv
Early detection of Alzheimer’s makes a big difference. @Starlab and @Neuroelectrics join PREDICTOM to help spot signs of dementia earlier using EEG, AI, and wireless brain scans. Read more: https://t.co/xOVq1tdTpw